The U.S. trade deficit in goods narrowed 2.5% to $96.8 billion in June, according to the Commerce Department’s advanced estimate released Wednesday.
Shares of Sage Therapeutics Inc. fell more than 18% premarket on Wednesday after a failed trial dealt a blow to the company’s collaboration with Biogen Inc.
“I would love to retire around 60 when she will be 80.”
Automotive financials are weighing on Tesla shares Wednesday, but Elon Musk — and many bulls — are focused on the future potential in autonomy and robotics.
Presumptive presidential nominee Kamala Harris picked up a huge endorsement on Monday, from CNBC’s Jim Cramer.
Oil futures rose Wednesday morning, bouncing from the lowest finish in six weeks, after industry data showed a decline in U.S. crude and gasoline inventories.
The ‘lock-in’ effect gripping the U.S. housing market is given a boost to battered mortgage bonds
The trial aimed to help people living with hemophilia benefit from a single infusion that would allow them to produce the needed clotting protein for an extended period, reducing the need for constant intravenous infusions or injections.
